iRhythm Technologies Inc (IRTC)
94.78
-3.92
(-3.97%)
USD |
NASDAQ |
May 17, 16:00
94.78
0.00 (0.00%)
After-Hours: 20:00
iRhythm Technologies Research and Development Expense (Quarterly): 16.99M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 16.99M |
| December 31, 2023 | 15.42M |
| September 30, 2023 | 16.31M |
| June 30, 2023 | 13.68M |
| March 31, 2023 | 14.84M |
| December 31, 2022 | 12.68M |
| September 30, 2022 | 11.45M |
| June 30, 2022 | 11.94M |
| March 31, 2022 | 10.54M |
| December 31, 2021 | 11.87M |
| September 30, 2021 | 8.685M |
| June 30, 2021 | 9.606M |
| March 31, 2021 | 8.51M |
| December 31, 2020 | 11.60M |
| September 30, 2020 | 8.768M |
| June 30, 2020 | 12.54M |
| March 31, 2020 | 8.415M |
| December 31, 2019 | 9.268M |
| Date | Value |
|---|---|
| September 30, 2019 | 13.50M |
| June 30, 2019 | 7.833M |
| March 31, 2019 | 6.699M |
| December 31, 2018 | 7.084M |
| September 30, 2018 | 5.086M |
| June 30, 2018 | 4.564M |
| March 31, 2018 | 4.019M |
| December 31, 2017 | 4.078M |
| September 30, 2017 | 3.79M |
| June 30, 2017 | 2.776M |
| March 31, 2017 | 2.621M |
| December 31, 2016 | 2.303M |
| September 30, 2016 | 1.635M |
| June 30, 2016 | 1.667M |
| March 31, 2016 | 1.545M |
| December 31, 2015 | 1.80M |
| September 30, 2015 | 1.651M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
7.833M
Minimum
Jun 2019
16.99M
Maximum
Mar 2024
11.72M
Average
11.74M
Median
Research and Development Expense (Quarterly) Benchmarks
| Abbott Laboratories | 684.00M |
| Alphatec Holdings Inc | 18.01M |
| AtriCure Inc | 19.84M |
| Intuitive Surgical Inc | 284.50M |
| RxSight Inc | 8.031M |